Idiopathic Retroperitoneal Fibrosis: A Retrospective Review of Clinical Presentation, Treatment, and Outcomes

submitted by: mcgheekkm

Dr. Tanaz Kermani, Assistant Professor of Medicine at Mayo Clinic, Rochester, provides an overview of their findings in a large series of patients with idiopathic retroperitoneal fibrosis which was published in the April 2011 issue of Mayo Clinic Proceedings.
Available at: http://tinyurl.com/3nw2u6z

Treatment of Epilepsy

submitted by: alex01
Michael Rogawski (University of California, Davis) summarizes his research on the antiepileptic activity of neurosteroids (e.g. ganaxolone, allopregnanolone). They are allosteric modulators of GABAA receptors and are active in many models of epilepsy. They are expected, however, to be most effective in catamenial epilepsy, infantile spasms or adult partial seizures. National Institutes of Health (NIH) is currently sponsoring a clinical trial of progesterone (precursor of allopregnanolone)...

Alzheimer's Disease

submitted by: alex01
Z. Khachaturian, PhD. - New approaches to the therapy of Alzheimer’s disease (AD) are discussed in video interviews of this series. According to Z. Khachaturian (Potomac, MD) substantial progress has been made during the last 10 years in our understanding of pathogenesis of Alzheimer’s disease as well as in the discovery of biomarkers and therapeutic approaches. In addition to cholinergic drugs, inhibitors of plaque formation have been discovered, but the currently available...

Mark Prichard (Treatment Session)

submitted by: hhv-6foundation

"New developments in therapies for HHV-6 infections"
6th International Conference on HHV-6 & 7 in Baltimore, Maryland, USA
Day 2 - June 21, 2008 - Treatment Session